Direct inhibition of Indian hedgehog expression by parathyroid hormone (PTH)/PTH-related peptide and up-regulation by retinoic acid in growth plate chondrocyte cultures.
Indian hedgehog (Ihh) is highly expressed in prehypertrophic chondrocytes in vivo and has been proposed to regulate the proliferation and maturation of chondrocytes and bone collar formation in the growth plate. In high-density cultures of rabbit growth-plate chondrocytes, Ihh mRNA was also expressed at the highest level in the prehypertrophic stage. To explore endogenous factors that regulate Ihh expression in chondrocytes, we examined the effects of various growth factors on Ihh mRNA expression in this system. Retinoic acid (RA) and bone morphogenetic protein-2 enhanced Ihh mRNA expression, whereas PTH/PTH-related peptide (PTHrP) markedly suppressed Ihh expression. RA at more than 10(-8) M induced the expression of Ihh and Patched 1 (Ptc1) within 3 h, before it increased the type X collagen mRNA level at 6-24 h. Cycloheximide blocked the up-regulation of Ihh by RA, indicating the requirement of de novo protein synthesis for this stimulation. These findings suggest that RA is involved in the up-regulation of Ihh during endochondral bone formation. In contrast to RA, PTH (1-84) at 10(-7) M abolished the mRNA expression of Ihh and Ptc1 within 2-4 h, before it suppressed the expression of type X collagen at 12-24 h. The inhibition of Ihh expression by PTH (1-84) did not require de novo protein synthesis. PTH (1-34), PTHrP (1-34), and (Bu)(2)cAMP also suppressed Ihh expression. On the other hand, Ihh has been reported to induce PTHrP synthesis in the perichondrium. Consequently, the direct inhibitory action of PTH/PTHrP on Ihh appears to be a negative feedback mechanism that prevents excess PTHrP accumulation in cartilage.
Yoshida
E
E
Department of Biochemistry, Hiroshima University Faculty of Dentistry, Hiroshima, 734-8553, Japan.
Noshiro
M
M
Kawamoto
T
T
Tsutsumi
S
S
Kuruta
Y
Y
Kato
Y
Y
D000818:Animals; D002454:Cell Differentiation; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology / Q000378:metabolism; D003094:Collagen / Q000235:genetics; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation; D006132:Growth Plate / Q000166:cytology; D053823:Hedgehog Proteins; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000235:genetics; D053495:Osteopontin; D010281:Parathyroid Hormone / Q000378:metabolism* / Q000494:pharmacology; D044162:Parathyroid Hormone-Related Protein; D000072079:Patched Receptors; D000072081:Patched-1 Receptor; D010446:Peptide Fragments / Q000378:metabolism* / Q000494:pharmacology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011506:Proteins / Q000235:genetics* / Q000378:metabolism* / Q000494:pharmacology; D012333:RNA, Messenger; D011817:Rabbits; D044168:Receptor, Parathyroid Hormone, Type 1; D011956:Receptors, Cell Surface; D018016:Receptors, Parathyroid Hormone / Q000235:genetics; D012795:Sialoglycoproteins / Q000235:genetics; D019379:Teriparatide / Q000378:metabolism* / Q000494:pharmacology; D013997:Time Factors; D015534:Trans-Activators; D014212:Tretinoin / Q000378:metabolism* / Q000494:pharmacology; D015854:Up-Regulation
D053823:Hedgehog Proteins; D008565:Membrane Proteins; C000606236:PTCH1 protein, human; C470121:PTHLH protein, human; D010281:Parathyroid Hormone; D044162:Parathyroid Hormone-Related Protein; D000072079:Patched Receptors; D000072081:Patched-1 Receptor; D010446:Peptide Fragments; D011500:Protein Synthesis Inhibitors; D011506:Proteins; D012333:RNA, Messenger; D044168:Receptor, Parathyroid Hormone, Type 1; D011956:Receptors, Cell Surface; D018016:Receptors, Parathyroid Hormone; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D015534:Trans-Activators; D053495:Osteopontin; D019379:Teriparatide; C054296:parathyroid hormone-related protein (1-34); D003609:Dactinomycin; D014212:Tretinoin; D003094:Collagen; D003513:Cycloheximide